Localization of indium-111 in human malignant tumor xenografts and control by chelators

Nuclear Medicine and Biology

Volumn 26, Issue 7, 1999, Pages 853-858

  Watanabe, Naoyuki ^a   Oriuchi, Noboru ^b   Endo, Keigo ^b   Inoue, Tomio ^b   Tanada, Shuji ^a   Murata, Hajime ^a   Kim, E Edmund ^c   Sasaki, Yasuhito ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

111In chloride; CaNa2EDTA; CaNa3DTPA; Human malignant tumor; Improvement of imaging quality

Indexed keywords

CHELATING AGENT; INDIUM CHLORIDE IN 111; PENTETATE CALCIUM TRISODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; HUMAN CELL; IMAGE QUALITY; MOUSE; NONHUMAN; NUDE MOUSE; RADIOTHERAPY; TUMOR XENOGRAFT;

ANIMALS; CALCIUM; CHELATING AGENTS; EDETIC ACID; FEMALE; HUMANS; INDIUM; INDIUM RADIOISOTOPES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PENTETIC ACID; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032752885     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00057-8     Document Type: Article

References (12)

1. 111In-chloride scanning in patients with focal defects on colloid liver scans. Radiology. 114:1975;403-406.
2. 169Yb binding substances in tumor tissues and liver . Eur. J. Nucl. Med. 7:1982;293-303.
3. Cantilena L.R., Klaassen C.D. Decreased effectiveness of chelation therapy with time after acute cadmium poisoning. Toxicol. Appl. Pharmacol. 63:1982;173-180.
4. 111In for tumor localization. J. Nucl. Med. 10:1969;343. [abstract].
5. Klaassen C.D. Toxicology. Goodman G.A., Rall T.W., Nies A.S., Taylor P. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th edn :1990;1592-1614 Pergamon Press, Elmsford, NY.
6. 111In-chlorides in mice. J. Nucl. Med. 16:1975;738-743.
7. Konikowski T., Jahns M.F., Haynie T.P., Glenn H.J. Brain tumor-scanning agents compared in an animal model. J. Nucl. Med. 16:1975;200-207.
8. Lavender J.P., Goldman J.M., Arnot R.N., Thakur M.L. Kinetics of indium-111 labelled lymphocytes in normal subjects and patients with Hodgkin's disease. Br. Med. J. 2:1977;797-799.
9. 111In labeled monoclonal antibody with chelator administration to host nude mice. Eur. J. Nucl. Med. 12:1987;573-575.
10. Pimm M.V., Perkins A.C., Baldwin R.W. Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody. Eur. J. Nucl. Med. 11:1985;300-304.
11. 111In-bleomycin kinetics in mice bearing transplantable tumors of lung, skin, and bone. J. Nucl. Med. 15:1974;273-278.
12. Rosoff B., Ritter S., Sulivan K., Hart H., Spencer-Laszlo H. Effect of chelating agents on the removal of yttrium and lanthanum from man. Health Phys. 6:1961;177-182.